Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
69.45
+0.03 (0.04%)
May 4, 2026, 12:07 PM EDT - Market open
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $5.99 billion as of May 4, 2026. Its market cap has increased by 700.26% in one year.
Market Cap
5.99B
Enterprise Value
5.23B
1-Year Change
700.26%
Ranking
Category
Stock Price
$69.45
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $5.99B, an increase of 5,263.22%. That is a compound annual growth rate of 48.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 5.45B | 114.50% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 6.28B |
| Cogent Biosciences | 6.26B |
| Centessa Pharmaceuticals | 6.12B |
| Terns Pharmaceuticals | 6.11B |
| Belite Bio | 6.09B |
| Celcuity | 6.07B |
| Apogee Therapeutics | 6.03B |
| Mirum Pharmaceuticals | 5.89B |